Volume 31, Supplement—December 2025
SUPPLEMENT ISSUE
Supplement
Persistence of Symptoms among Commercially Insured Patients with Coccidioidomycosis, United States, 2017–2023
Ian Hennessee1
, Samantha L. Williams, Kaitlin Benedict, Dallas J. Smith, George R. Thompson, and Mitsuru Toda
, Samantha L. Williams, Kaitlin Benedict, Dallas J. Smith, George R. Thompson, and Mitsuru Toda
Table 1
Demographic characteristics, underlying conditions, and coccidioidomycosis type among 2,640 commercially insured patients with coccidioidomycosis, United States, July 2017‒January 2023*
| Characteristic | No. (%) |
|---|---|
| Sex | |
| M | 1,363 (52) |
| F |
1,277 (48) |
| Median age, y (IQR) |
51.0 (39.0–60.0) |
| Age group, y | |
| <18 | 123 (5) |
| 18‒44 | 803 (30) |
| 45‒64 | 1,326 (50) |
| >65 |
388 (15) |
| US Census region of primary beneficiary's residence† | |
| Northeast | 80 (3) |
| Midwest | 219 (8) |
| South | 266 (10) |
| West |
2,047 (78) |
| Rural status‡ | |
| Rural | 123 (5) |
| Nonrural |
2,304 (95) |
| Underlying conditions | 898 (66) |
| Asthma or COPD | 633 (24) |
| Diabetes | 426 (18) |
| Hypertension | 850 (35) |
| Immunosuppression§ |
971 (40) |
| Coccidioidomycosis type on index date | |
| Pulmonary | 1,336 (51) |
| Cutaneous | 52 (2) |
| Disseminated | 118 (4) |
| Other or unspecified | 1,277 (48) |
*Values are no. (%) except as indicated. COPD, chronic obstructive pulmonary disease; IQR, interquartile range. †Regions were derived from US Census regions (https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf). ‡Rural versus nonrural status were based on US Census metropolitan statistical area designation. §Immunosuppression related to autoimmune disease, cancer, HIV, solid organ transplant, immunosuppressive medication, or a combination of those factors.
1Current affiliation: The Carter Center, Atlanta, Georgia, USA
Page created: September 02, 2025
Page updated: January 22, 2026
Page reviewed: January 22, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.